1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Holly LaFon
Holly LaFon
Articles (6665) 

Invesco European Growth Fund Comments on MorphoSys

November 11, 2013 | About:

MorphoSys (XTER:MOR) is a German biotechnology company with a proprietary technology to develop human antibodies for specific diseases. The company signed two licensing deals (with GlaxoSmithKline PLC and Celgene Corp.) for its proprietary compounds, providing outside validation for its technology as well as upfront cash and future royalty payments.

From Invesco European Growth Fund’s third quarter 2013 commentary.


Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


GuruFocus Mobile App


User Generated Screeners


holtzmartinScandinavian below 52 week hig
holtzmartinUS below 52 week high
minweiyScreener End Dec 2016
pbarker46Below 5 year high
DANGORDONJ GREEN
ltsaiP/B High
valueinvestment101-PEG-Recovery-PB
pbarker46Median PS
pbarker46High & Low PB
pbarker46Low payout & Hist. PB
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK